Jiaxing Antikang Biotechnology
A drug developer focused on respiratory anti-infections.
Launch date
Market cap
-
Enterprise valuation
€125m (Public information from Jun 2024)
Kaohsiung Taiwan (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY200m Valuation: CNY1.0b | Series A | |
| Total Funding | €25.0m | ||